Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Accidental thiabendazole poisoning (disorder) |
Causative agent (attribute) |
False |
Thiabendazole |
Inferred relationship |
Some |
|
Intentional thiabendazole poisoning |
Causative agent (attribute) |
False |
Thiabendazole |
Inferred relationship |
Some |
|
Thiabendazole poisoning of undetermined intent |
Causative agent (attribute) |
False |
Thiabendazole |
Inferred relationship |
Some |
|
Thiabendazole adverse reaction (disorder) |
Causative agent (attribute) |
False |
Thiabendazole |
Inferred relationship |
Some |
|
Allergy to tiabendazole |
Causative agent (attribute) |
False |
Thiabendazole |
Inferred relationship |
Some |
|
Thiabendazole overdose |
Causative agent (attribute) |
False |
Thiabendazole |
Inferred relationship |
Some |
|
Accidental thiabendazole overdose |
Causative agent (attribute) |
False |
Thiabendazole |
Inferred relationship |
Some |
|
Intentional thiabendazole overdose |
Causative agent (attribute) |
False |
Thiabendazole |
Inferred relationship |
Some |
|
Thiabendazole overdose of undetermined intent |
Causative agent (attribute) |
False |
Thiabendazole |
Inferred relationship |
Some |
|
Product containing tiabendazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thiabendazole |
Inferred relationship |
Some |
|
Tiabendazole 500 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thiabendazole |
Inferred relationship |
Some |
|
Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thiabendazole |
Inferred relationship |
Some |
|
Thiabendazole 500mg/5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thiabendazole |
Inferred relationship |
Some |
|
Poisoning by thiabendazole |
Causative agent (attribute) |
False |
Thiabendazole |
Inferred relationship |
Some |
|